Tenofovir Alafenamide (Taf) 25 mg TAF per tablet Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 25 mg TAF per tablet
Reference Brands: Vemlidy (EU & US), Genvoya (India)
Category: Hepatitis
Tenofovir Alafenamide (TAF) is a 25 mg oral antiviral used to treat chronic Hepatitis B and HIV-1 infections. It provides higher drug levels inside cells with fewer side effects on kidneys and bones compared to TDF. Marketed as Vemlidy® for Hepatitis B, TAF is approved by FDA and EMA and widely used in the US and EU. It’s a key option for pharma B2B suppliers and healthcare providers managing viral infections.
Product Description:
Tenofovir Alafenamide (TAF) is a next-generation nucleotide reverse transcriptase inhibitor (NRTI) used for the treatment of chronic Hepatitis B virus (HBV) infection and HIV-1. Available as oral tablets, typically in 25 mg strength, TAF delivers higher intracellular concentrations of the active drug with lower plasma exposure, improving safety and reducing kidney and bone side effects compared to Tenofovir Disoproxil Fumarate (TDF). Marketed under the brand name Vemlidy® (for HBV) and as part of combination therapies for HIV, TAF is FDA- and EMA-approved, widely used by pharma B2B suppliers and healthcare providers in the US and EU.
Tenofovir Alafenamide (Taf) — third party manufacturing & bulk supply
Tenofovir Alafenamide (Taf) 25 mg TAF per tablet is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Tenofovir Alafenamide (Taf) listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Tenofovir Alafenamide (Taf) →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Tenofovir Alafenamide (TAF) is used to treat HIV-1 infection in combination with other antiretroviral agents and chronic hepatitis B virus (HBV) infection in adults.
Tenofovir Alafenamide is a prodrug of tenofovir that delivers higher concentrations of the active metabolite to target cells while reducing systemic exposure, improving safety and tolerability.
Vemlidy (for HBV) and Genvoya / Descovy (for HIV-1, as part of combination therapies).
Gilead Sciences.
Tenofovir Alafenamide.
Vemlidy, Genvoya, Descovy.
Manufactured in the USA and distributed globally including USA, EU, India, and Asia-Pacific markets.
Related Products
Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir
Strength:
Ombitasvir 12.5 mg / Paritaprevir 75 mg / Ritonavir 50 mg (tablet)+ Dasabuvir 250 mg (tablet)
Form: Tablet
Reference Brands: Viekira Pak® (US); Viekirax® + Exviera® (EU)
View Details
Ribavirin
Strength:
Tablet:200 mg, 400 mg, 600mg; Capsule:200 mg; Solution:40 mg/mL
Form: Tablets, Capsules and Oral Solution
Reference Brands: Rebetol®, Copegus®, Virazole®(EU & US)
View Details
Adefovir Dipivoxil
Strength:
10 mg
Form: Oral tablets
Reference Brands: Hepsera® (EU & US)
View Details
Tenofovir Disoproxil Fumarate(Tdf) Tablets
Strength:
300 mg
Form: Oral tablets
Reference Brands: Viread (EU & US), Truvada (India)
View DetailsQuick Response Guaranteed | Verified Suppliers
